ask="N/A"
ask_size="N/A"
average_daily_volume="15912"
bid="N/A"
bid_size="N/A"
book_value="0.34"
change="-0.10"
change_from_200_day_moving_average="0.57"
change_from_50_day_moving_average="0.25"
change_from_52_week_high="-2.10"
change_From_52_week_low="2.75"
change_in_percent="-1.68%"
close="5.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.42"
ebitda="-10.75M"
eps_estimate_current_year="-0.48"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.51"
ex_dividend_date="N/A"
float_shares="2879000"
high="6.08"
high_52_weeks="7.95"
last_trade_date="3/3/2017"
last_trade_price="5.85"
last_trade_size="100"
last_trade_time="4:45pm"
low="5.78"
low_52_weeks="3.10"
market_capitalization="168.11M"
moving_average_200_day="5.28"
moving_average_50_day="5.60"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.38"
open="5.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+10.83%"
percent_change_from_50_day_moving_average="+4.45%"
percent_change_from_52_week_high="-26.42%"
percent_change_from_52_week_low="+88.71%"
previous_close="5.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="17.35"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28736000"
short_ratio="4.26"
stock_exchange="ASE"
symbol="OCX"
volume="11862"
weeks_range_52="3.10 - 7.95"
